期刊文献+

黑升麻在中重度子宫内膜异位症GnRH-a反加治疗中的疗效评估 被引量:4

Assessment of efficacy of Black cohosh in addback therapy on GnRH-a treatment for severe endometriosis
下载PDF
导出
摘要 目的:比较黑升麻和替勃龙在中重度子宫内膜异位症腹腔镜术后GnRH-a反加治疗中的疗效。方法:前瞻性随机对照比较中重度子宫内膜异位症腹腔镜术后患者90例,分为戈舍瑞林+黑升麻组、戈舍瑞林+替勃龙组、戈舍瑞林组,各30例,分析各组用药3个月后血清雌二醇(E2)、促卵泡激素(FSH)水平;子宫内膜厚度;Kupperman(KMI)评分;视觉疼痛症状评分法(VAS)评分;血清骨钙素(BGP);CA125、肝肾功能、血脂等变化。结果:戈舍瑞林+替勃龙组血清E2水平显著高于戈舍瑞林+黑升麻组及戈舍瑞林组(P均<0.05),FSH显著低于戈舍瑞林+黑升麻组及戈舍瑞林组(P均<0.05),戈舍瑞林+黑升麻组和戈舍瑞林组间无差异(P>0.05);戈舍瑞林组KMI评分明显高于戈舍瑞林+替勃龙组和戈舍瑞林+黑升麻组(P<0.05),而戈舍瑞林+替勃龙组和戈舍瑞林+黑升麻组间无差异(P>0.05);戈舍瑞林+替勃龙组血清BGP浓度显著低于戈舍瑞林组和戈舍瑞林+黑升麻组(P均<0.05),而戈舍瑞林组和戈舍瑞林+黑升麻组间无差异(P>0.05)。各组间EM、VAS评分、CA125、肝肾功能及血脂等均无明显差异(P>0.05)。结论:黑升麻是中重度子宫内膜异位症腹腔镜术后GnRH-a反加治疗安全有效的选择之一。 Objective:To compare the efficacy of Black cohosh and Tibolone in addback therapy on Gonadotropin releasing hormone analogues treatment for severe endometriosis after laparoscopic surgery.Methods:90 cases of severe endometriosis patients who underwent GnRH-a treatment after laparoscopic surgery were retrospectively analyzed.They were randomly divided into three groups:GnRH-a +Black cohosh group(n=30),GnRH-a +Tibolone group(n=30),and GnRH-a group(n=30).Three months later,the degree of pain was measured according to a visual analog scale(VAS),the menopausal symptoms were assessed with the Kupperman Menopausal Index(KMI).Serum E2,FSH,BGP,CA125,Lipid,electrolytes,Liver and kidney function were measured respectively.Endometrial thickness was detected by Ultrasound.Results:The level of serum E2 in Tibolone group was significantly higher than that in Black cohosh group and GnRH-a group(P0.05);and the level of serum FSH in Black cohosh group and GnRH-a group was significantly lower than that in Tibolone group(P0.05).The score of KMI significantly increased in GnRH-a group(P0.05),but there was no significant differences between Tibolone group and Black cohosh group(P0.05).The serum of BGP significantly decreased in Tibolone group(P0.05),but there was no significant difference between GnRH-a group and Black cohosh group(P0.05).The score of VAS,endometrial thickness,serum CA125,lipid,liver and kidney function were all similar in three groups(P0.05).Conclusion:Black cohosh add-back therapy can relieve the side effect of GnRH-a,and it may be a better choice for add-back therapy in GnRH-a treatment for severe endometriosis after laparoscopic surgery.
出处 《现代妇产科进展》 CSCD 2012年第8期617-620,共4页 Progress in Obstetrics and Gynecology
关键词 子宫内膜异位症 促性腺激素释放激素 升麻属 反加治疗 黑升麻 替勃龙 Endometriosis Gonadotropin-releasing hormone Cimicifuga Addback therapy Black cohosh Tibolone
  • 相关文献

参考文献13

  • 1Giudice LC,Kao LC.Endometriosis[J].Lancet,2004,364(9447):1789-1799.
  • 2子宫内膜异位症的诊断与治疗规范[J].中华妇产科杂志,2007,42(9):645-648. 被引量:565
  • 3陈孝平.外科学[M].北京:人民出版社,2005:58.
  • 4Olive DL.The role of add-back therapy in the UnitedStates[J].Drugs Today,2005,41:23-26.
  • 5Barbieri RL.Hormone treatment of endometriosis:the es-trogen threshold hypothesis[J].Am J Obstet Gynecol,1992,166(2):740-745.
  • 6马晓艳,白文佩,胡丽娜.黑升麻治疗绝经综合征的作用机制探讨[J].实用妇产科杂志,2010,26(6):422-425. 被引量:19
  • 7李轶琳,崔满华,高双.黑升麻类药物莉芙敏治疗更年期症状临床疗效观察[J].现代妇产科进展,2011,20(6):462-465. 被引量:12
  • 8Volker V,Gunter E,Wolfgang W.Black cohosh:just an-other phytoestrogen[J].Trends Endocrinol Metabo,2005,16(5):214-221.
  • 9NIH.Workshop on the safety of b lack cohosh in clinicalstudies[M/OL].NIH,2004:22-28[2009-11-10].ht-tp://nccam.nih.gov/news/events/blackcohosh/blackco-hosh_mtngsumm.htm.
  • 10Liske E,Hanggi W,Henneicke-von Zepelin HH,et al.Physi-ological investigation of a unique extract of black cohosh(Cimicifugae racemosae rhizoma):a 6-month clinical studydemonstrates no systemic estrogenic effect[J].J WomensHealth Gend Based Med,2002,11(2):163-174.

二级参考文献40

  • 1Hickey M,Davis SR,Sturdee DW.Treatment of menopausal symptoms:what shall we do now[J].Lancet,2005,366:409 -421.
  • 2Nuntanakom P,Jiang B,Einbond LS,et al.Polyphenolic constituents of Actaea racemosa[J].J Nat Prod,2006,69(3):314 -318.
  • 3Kennelly EJ,Baggett S,Nuntanakorn P,et al.Analysis of thirteen populations of black cohosh for formononetin[J].Phytomedicine,2002,9(5):461 -467.
  • 4Hostanska K,Nisslein T,Freudenstein J,et al.Cimicifuga racemosaextract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis[J].Breast Cancer Res Treat,2004,84(2):151 -160.
  • 5Hagels H,Baumert-Krauss J,Freudenstein J.Composition of phenolic constituents in cimicifuga racemosa,Abstract P1B/03 in:Abstracts of International congress and 48th Annual Meeting of the Society of Medicinal Plant Research,Zürich,3 -7 Septenber,2000.
  • 6Li JX,Yu ZY.Cimicifugae rhizoma:from origins,bioactive constituents to clinical outcomes[J].Current medicinal chemistry,2006,13(24):2927 -2951.
  • 7Liske E,Hanggi W,Henneicke-von Zepelin HH.Physiological investigation of a unique extract of black cohosh (cimicifugae racemosae rhizoma):a 6-month clinical study demonstrates no systemic estrogenic effect[J].Journal of Women's Health & Gender-based Medicine,2002;11(2):164-172.
  • 8Kretzschmar G,Nisslein T,Zierau O,et al.No estrogen-like effects of an isopropanolic extract of rhizoma cimicifugae racemosae on uterus and yena cava of rats after 17 day treatment[J].J Steroid Biochem Mol Biol,2005,97(3):271 -277.
  • 9Borrelli F,Emst E.Cimicifuga racemosa:a systematic review of its clinical efficacy[J].Eur J Clin Pharmacol,2002,58(4):235 -241.
  • 10Rebbeck TR,Troxel AB,Norman S.A retrospective case-control study of the use of hormone-related supplements and association with breast cancer[J].Int J Cancer,2007,120(7):1523-1528.

共引文献980

同被引文献26

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部